NCT01656356View on ClinicalTrials.gov

Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2012

Primary Completion Date

August 31, 2012

Conditions
Preventive Avian Flu
Interventions
BIOLOGICAL

Avian Flu Vaccine

BIOLOGICAL

Placebo

Trial Locations (1)

10400

Faculty of Tropical Medicine, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT01656356 - Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers | Biotech Hunter | Biotech Hunter